View Single Post
Old Thu May 12, 2011, 11:33 AM
Sally C Sally C is offline
Join Date: Dec 2010
Location: Chesterfield, Va.
Posts: 457
New Promacta (Eltrombopag) Clinical Trial at NIH

My husband has hypocellular MDS with refractory platelets and red cells. He received Campath at NIH in April 2009. He has just started in a brand new clinical trial for Promacta for low to Int. 2 risk MDS patients. They have had good success with AA patients. It is specifically for platelets but it has also helped with red cells as well. Don is their very first "guinea pig" and they have a second one coming in next Monday. They are very anxious to get additional MDS patients for the study. Here is the contact info for the clinical trial. NIH is absolutely wonderful!!! Extremely accessible!
God Bless,

Barbara Weinstein RN BSN CCRP
NHLBI/ Research Nurse Specialist
Building 10 CRC Room 5130
10 Center Drive
Bethesda, MD 20892
phone: 301-594-4180
fax: 301-594-1290

Last edited by Sally C : Mon Sep 19, 2011 at 08:23 AM. Reason: Contact information changed
Reply With Quote